Diagonal Bio AB (DIABIO) — Net Asset Momentum
Diagonal Bio AB (DIABIO) recorded a net asset momentum of 15.8% as of December 2024, with net assets of Skr24.59 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See DIABIO defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Diagonal Bio AB Net Asset Momentum (2020–2024)
This chart tracks Diagonal Bio AB's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is +15.8%, with net assets of Skr24.59 Million SEK as of December 2024. Read Diagonal Bio AB (DIABIO) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Diagonal Bio AB (2020–2024)
The table below shows the complete annual net asset history for Diagonal Bio AB from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Diagonal Bio AB worth.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr24.59 Million | Skr27.13 Million | Skr2.54 Million | ▲ +15.8% |
| 2023 | Skr21.25 Million | Skr28.51 Million | Skr7.26 Million | ▼ -32.0% |
| 2022 | Skr31.25 Million | Skr34.03 Million | Skr2.78 Million | ▼ -7.7% |
| 2021 | Skr33.87 Million | Skr36.01 Million | Skr2.14 Million | ▲ +280.8% |
| 2020 | Skr8.89 Million | Skr9.97 Million | Skr1.08 Million | — |